Dr. Diana Saravia, MD

Dr. Saravia practices at Cleveland Clinic Florida - Weston in Weston, Florida.

Dr. Saravia's NPI, 1619388022, was assigned on May 20, 2014. Dr. Saravia graduated from University of Miami, Miller School of Medicine in 2014. Dr. Saravia holds Florida license ME144357.

Dr. Saravia's primary practice is Cleveland Clinic Florida - Weston, at 2950 Cleveland Clinic Blvd, Weston, FL 33331 in Broward County. The practice phone is (954) 689-5000.

Dr. Saravia's primary practice is Cleveland Clinic Florida - Weston in Weston, Florida. Dr. Saravia is also affiliated with Cleveland Clinic Weston Hospital. The medical group on file is Cleveland Clinic Florida. Dmand AI also links Dr. Saravia to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Saravia practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Saravia's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Saravia is board certified in internal medicine by the American Board of Internal Medicine. Dr. Saravia is licensed in Florida.

Dmand AI lists breast cancer, chronic anemia, lung cancer and purpura and thrombocytopenia among the conditions Dr. Saravia treats.

CMS data shows 324 Medicare services from Dr. Saravia across 3 procedure codes in 2024, for 98 Medicare patients. Medicare paid $29,057 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 98 Medicare patients who saw Dr. Saravia in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have cancer, and 75% have high blood pressure. 12% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Saravia's median patient age at 69, with 77% women.

In 2024, Dr. Saravia wrote 454 Medicare Part D claims for 137 patients. 89% of them were for generic drugs. CMS names the drug for 305 of them, across 6 drugs with 11 or more claims each, at $24,571 in total drug cost. In 2023, CMS named 228 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Saravia for performance year 2024, reported through an alternative payment model (APM). Dr. Saravia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Saravia as offering telehealth.

Dmand AI links 12 papers to Dr. Saravia, published from 2014 to 2023. 2022 was the busiest year, with 3. The most frequent topics are Lung Neoplasms, Breast Neoplasms and Carcinoma, Non-Small-Cell Lung. Dr. Saravia has published most often in Breast. Dr. Saravia's most frequent co-authors are Zeina Ahmad Nahleh, MD, Marita Yaghi, MD and Hong Liang, DO.

Dmand AI links Dr. Saravia to 1 clinical trial. Conditions studied include Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 177 general payments to Dr. Saravia from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. AstraZeneca Pharmaceuticals LP paid the most, $567.

Dr. Saravia graduated from University of Miami, Miller School of Medicine in 2014.

Dr. Saravia is in network with 13 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.